BACKGROUND: Annual influenza vaccination provides an opportunity to administer a
booster dose of diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccine …

Introduction The immunogenicity and safety of one dose of Tdap-IPV (tetanus, diphtheria,
acellular pertussis and inactivated poliomyelitis vaccine) and two doses of Td-IPV (tetanus …

BACKGROUND: Older adults, especially those over 65 years, are at risk of more severe
morbidity from diphtheria, tetanus and pertussis and may transmit pertussis to unvaccinated …

Many countries recommend diphtheria, tetanus and/or poliomyelitis boosters in adolescents
or adults and the need for pertussis booster vaccination beyond childhood is increasingly …

BACKGROUND: Pertussis can cause significant morbidity in elderly patients, who can also
transmit this disease to infants and young children. There is little data available on the use of …

Background Pertussis in adults and adolescents could be reduced by replacing traditional
tetanus and diphtheria (Td) boosters with reduced-antigen-content diphtheria–tetanus …

In view of the continuing risk of contracting tetanus, diphtheria and poliomyelitis, and the well-
documented decline in immunity with time, the need for booster vaccinations is substantial …

Objective: To evaluate immunogenicity and reactogenicity of primary vaccination with
reduced-antigen-content diphtheria-tetanus-acellular pertussis (dTpa) or dTpa-inactivated …

Introduction: Influenza and pneumococcal vaccines are the most regularly prescribed
vaccines amongst adults< 65 years of age. Pertussis booster vaccines (available as …

At 60 months post-vaccination, adults (mean age 45.6 years) randomised to receive
combined reduced-antigen-content diphtheria–tetanus and acellular pertussis vaccine …